GT Biopharma SG&A Expense (Quarterly) Analysis

GT Biopharma Inc (GTBP)

3.12 -0.15 (-4.59%) USD | NASDAQ | May 17, 16:00

3.83 +0.71 (+22.76%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1991. Upgrade now.

Date	Value
December 31, 2023	1.811M
September 30, 2023	1.758M
June 30, 2023	1.526M
March 31, 2023	2.015M
December 31, 2022	2.936M
September 30, 2022	4.28M
June 30, 2022	1.875M
March 31, 2022	3.355M
December 31, 2021	11.87M
September 30, 2021	4.946M
June 30, 2021	3.742M
March 31, 2021	27.36M
December 31, 2020	1.958M
September 30, 2020	2.029M
June 30, 2020	1.546M
March 31, 2020	0.746M
December 31, 2019	0.858M
September 30, 2019	3.585M
June 30, 2019	2.125M
March 31, 2019	3.222M
December 31, 2018	1.859M
September 30, 2018	5.035M
June 30, 2018	1.906M
March 31, 2018	3.687M
December 31, 2017	5.734M

Date	Value
September 30, 2017	126.33M
June 30, 2017	1.044M
March 31, 2017	1.394M
December 31, 2016	0.572M
September 30, 2016	2.28M
June 30, 2016	1.871M
March 31, 2016	3.676M
December 31, 2015	2.383M
September 30, 2015	2.552M
June 30, 2015	1.451M
March 31, 2015	1.568M
December 31, 2014	1.64M
September 30, 2014	0.547M
June 30, 2014	0.112M
March 31, 2014	0.101M
December 31, 2013	0.251M
September 30, 2013	0.20M
June 30, 2013	0.118M
March 31, 2013	0.366M
December 31, 2012	0.897M
September 30, 2012	1.438M
June 30, 2012	1.031M
March 31, 2012	0.397M
December 31, 2011	1.083M
September 30, 2011	0.535M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.746M

Minimum

Mar 2020

27.36M

Maximum

Mar 2021

4.228M

Average

2.029M

Median

Sep 2020

SG&A Expense (Quarterly) Benchmarks